About the Authors

Alejandro García Castaño

Affiliation BioCruces Health Research Institute, Ciberer, Cruces University Hospital, Bizkaia, Spain

Gustavo Pérez de Nanclares

Affiliation BioCruces Health Research Institute, Ciberer, Cruces University Hospital, Bizkaia, Spain

Leire Madariaga

Affiliations Pediatric Nephrology, Cruces University Hospital, Bizkaia, Spain, Department of Pediatrics, School of Medicine and Odontology, University of Basque Country UPV/EHU, Bizkaia, Spain

Mireia Aguirre

Affiliation Pediatric Nephrology, Cruces University Hospital, Bizkaia, Spain

Álvaro Madrid

Affiliation Pediatric Nephrology, Vall d’Hebron University Hospital, Universitat Autonoma, Barcelona, Spain

Sara Chocrón

Affiliation Pediatric Nephrology, Vall d’Hebron University Hospital, Universitat Autonoma, Barcelona, Spain

Inmaculada Nadal

Affiliation Pediatric Nephrology, Virgen del Camino Hospital, Pamplona, Spain

Mercedes Navarro

Affiliation Pediatric Nephrology, La Paz University Hospital, Madrid, Spain

Elena Lucas

Affiliation Pediatrics, Manises Hospital, Valencia, Spain

Julia Fijo

Affiliation Pediatric Nephrology, Virgen del Rocío Hospital, Sevilla, Spain

Mar Espino

Affiliation Pediatric Nephrology, Fundación Alcorcón University Hospital, Madrid, Spain

Zilac Espitaletta

Affiliation San Ignacio University Hospital, Bogotá, Colombia

Víctor García Nieto

Affiliation Pediatric Nephrology, Nuestra Señora de Candelaria University Hospital, Tenerife, Canarias, Spain

David Barajas de Frutos

Affiliation Pediatric Nephrology, Virgen de las Nieves Hospital, Granada, Spain

Reyner Loza

Affiliation Nephrology Unit, Cayetano Heredia University, Cayetano Heredia Hospital, Lima, Peru

Guillem Pintos

Affiliation Germans Trias i Pujol University Hospital, Badalona, Spain

Luis Castaño

Affiliations BioCruces Health Research Institute, Ciberer, Cruces University Hospital, Bizkaia, Spain, Department of Pediatrics, School of Medicine and Odontology, University of Basque Country UPV/EHU, Bizkaia, Spain, Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain

RenalTube Group

Membership of RenalTube is provided in the Acknowledgments.

Affiliations BioCruces Health Research Institute, Ciberer, Cruces University Hospital, Bizkaia, Spain, Pediatric Nephrology, Vall d’Hebron University Hospital, Universitat Autonoma, Barcelona, Spain, Pediatric Nephrology, Nuestra Señora de Candelaria University Hospital, Tenerife, Canarias, Spain, Pediatric Nephrology, Asturias Central University Hospital, Oviedo, Asturias, Spain

Gema Ariceta

gariceta@vhebron.net

Affiliation Pediatric Nephrology, Vall d’Hebron University Hospital, Universitat Autonoma, Barcelona, Spain

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceptualization: AGC GPN LM LC GA. Formal analysis: AGC GPN. Funding acquisition: LM LC GA. Investigation: AGC GPN. Methodology: AGC GPN LC. Project administration: LC GA. Resources: LM MA AM SC IN MN EL JF ME ZE VGN DBF RL GP RenalTube Group LC GA. Validation: AGC GPN LC. Visualization: AGC GPN LM LC GA. Writing – original draft: AGC GPN LM LC GA.